Roflumilast Tablet
Product Images NDC 31722-623

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Roflumilast (NDC 31722-623). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

This is a table of drugs showing their fold changes in Cmax and AUC compared to reference, with recommendations for use or dose adjustment. Some drugs show a caution while others do not require any dose adjustment. However, the drug Rifampicin is not recommended.*

FDA Label Image

Roflumilastcamberlogo (Roflumilastcamberlogo)

FDA Label Image

Roflumilastcontlabel500mcg-30s (Roflumilastcontlabel500mcg 30s)

Roflumilast Tablets is a prescription drug containing 500mcg of Roflumilast as the active ingredient. It is recommended for adults to take one tablet by mouth once a day. The medication guide must be provided separately to each patient. The drug should be kept out of the reach of children and stored at a temperature of 20-25°C. Full prescribing information can be found in the package insert. The manufacturer is Camber Pharmaceuticals, Inc, and the drug is manufactured by Hetero Labs Limited in Hyderabad, India. Contact number of Camber Pharmaceuticals is also provided.*

FDA Label Image

Roflumilastcontlabel500mcg-90s (Roflumilastcontlabel500mcg 90s)

This is a description of Roflumilast Tablets provided by Camber Pharmaceuticals, Inc. Each tablet contains 500 mcg of Roflumilast. These tablets are recommended for adult use only with a daily dosage of one tablet taken orally. A Medication Guide is provided separately to each patient by the pharmacist. These tablets should be kept out of the reach of children and stored at controlled room temperature. A full prescribing information package insert is available. The manufacturing of Roflumilast Tablets is licensed to Hetero Labs Limited in India.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.